There are still some kinks to be ironed out, including risks of hemolysis and valve thrombosis, to put things on par with ...

Erlanger Health announces the recent completion of surgeries using new Pulsed Field Ablation (PFA) technology to better treat patients battling atrial fibrillation (AFib). Officials said, "As the ...

EMPAVELI's key market opportunities include its strong differentiation through C3 inhibition, capturing PNH patients inadequately controlled by C5 inhibitors. Expansion into rare kidney diseases, ...

Agios Pharmaceuticals has submitted a supplemental New Drug Application to the FDA seeking accelerated approval of mitapivat for sickle cell disease, supported by Phase 2/3 RISE UP data showing ...

Glomerular hyperfiltration was observed in 82.6% of 46 pediatric patients with sickle cell disease, while an elevated urinary protein-creatinine ratio affected 32.6%.

Document suggests federal health agency pointed out some of the same concerns repeatedly since 2022 without resolution ...

A Brit living in Spain has issued a stark warning after she was bitten by a venomous spider which led to infection and ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 11:30 AM EDTCompany ParticipantsMichael Bodner - Global ...

Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session Company to host investor conference call and webcast during EHA ...

Cardiac intensive care units are specialized, high-acuity, and resource-intensive environments for the care of critically ill patients with cardiovascular disease. Over the past 60 years, medical and ...

Agios Pharmaceuticals is seeking accelerated approval from the U.S. FDA for its oral medication mitapivat for treating sickle ...

Jaundice is when the skin and eyes turn yellow due to high bilirubin levels. Jaundice in adults can be caused by liver problems, broken red blood cells, or blocked bile ducts. Neonatal jaundice is ...